Recent review of AOSD suggests:
– AOSD & SJIA are the same
– Classify dz as systemic or articular
– #MAS occurs in up to 23%
– Yamaguchi & Fautrel criteria are widely used
– Cytokines important: IL-1, IL-6, IL-18, IL-37
– only Canakinumab is FDA-approved
https://t.co/4ERA56Wqcb https://t.co/FkIWxIrwxX